Details of Disease

General Information of Disease (ID: DISQJXI8)

• Disease Name: Warm autoimmune hemolytic anemia
• Synonyms: warm antibody autoimmune hemolytic anemia; warm-reacting-antibody hemolytic anemia; warm antibody hemolytic anemia; warm antibody hemolytic anaemia; warm antibody autoimmune hemolytic anaemia; warm-reacting-antibody hemolytic anaemia; warm antibody AIHA; wAIHA; warm AIHA; wAHA; Warm Autoimmune Hemolytic Anemia
• Disease Class: 3A20: Acquired haemolytic anaemia
• Definition: Warm autoimmune hemolytic anemia is the most common form of autoimmune hemolytic anemia defined by the presence of warm autoantibodies against red blood cells (autoantibodies that are active at temperatures between 37-40B0C).
• Disease Hierarchy:
  DIS7MS3M: Autoimmune haemolytic anaemia
  DISQJXI8: Warm autoimmune hemolytic anemia
• ICD Code: ICD-11: ICD-11: 3A20.0
• Disease Identifiers:
  MONDO ID: MONDO_0019532
  UMLS CUI: C0272118
  MedGen ID: 450541
  Orphanet ID: 90033
  SNOMED CT ID: 3978000

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Nipocalimab?	DM0DYAX	Phase 3	Monoclonal antibody	[1]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] ClinicalTrials.gov (NCT04119050) Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia: A Multicenter, Randomized, Double-blind, Placebo-controlled Study With a Long-term Open-label Extension. U.S.National Institutes of Health.